Jianjun Liu is the deputy executive director of A*STAR’s Genome Institute of Singapore (GIS). His main research interest focuses on understanding the genetic basis of human disease inheritance and susceptibility. His laboratory pursues collaborative research with the goal of discovering genetic variants that influence disease susceptibility, progression, and treatment outcome by employing both candidate gene-based and genome-wide association analyses. Largely working on Asian populations, his team studies diverse disease phenotypes such as cancers, autoimmune and inflammatory diseases, neurological and psychiatric disorders, metabolic and cardiovascular diseases, and infectious diseases. This has led to the discovery of many novel susceptibility genes involved in complex human diseases.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)